BioSpace

Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...
BioSpace

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its ...
BioSpace

Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduc…

GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michigan iv ...
BioSpace

OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia

The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies ...
BioSpace

Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel ...
BioSpace

UCB announces U.S. FDA approval for ZILBRYSQ® (zilucoplan) autoinjector self-administration for adults living with generalized myasthenia gravis

ZILBRYSQ is the first and only macrocyclic peptide C5 inhibitor approved as a self-administered once-daily, subcutaneous ...
BioSpace

FDA issues warning over Eurofins’ selective recording that ‘compromises’ data

Inconsistent reporting at a Pennsylvania site affected microbiological analyses of components and drug products that ...
BioSpace

Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors

Curis, Inc. (Nasdaq: CRIS) ("Curis" or the "Company"), a biotechnology company focused on the development of emavusertib ...
BioSpaceOpinion

Opinion: iPSCs come of age, powering breakthroughs in the lab and clinic

After years of quiet maturation, new approach methodologies and emerging clinical success for cell therapies are fueling ...
BioSpace

From Taiwan to the World: PharmaEssentia Builds a Scientist-Led, Fully Integrated Global Biopharmaceutical Company with Patients at Its Core

PharmaEssentia Corporation (TWSE: 6446), a Taiwan-based biopharmaceutical company, is expanding its global presence through ...
BioSpace

City’s IPO soars to $200M, with proceeds supporting thromboembolic disease pipeline

City Therapeutics will join a slew of biotechs that have entered the public markets this year, with a $200 million raise that landed above expectations.
BioSpace

Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA

Omeros Corporation (Nasdaq: OMER) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...